Literature DB >> 6454481

Inhibition by two diphosphonates of bone lysis in tumor-conditioned media.

A Jung, B Mermillod, C Barras, M Baud, B Courvoisier.   

Abstract

In order to test the effect of diphosphonates in inhibiting bone lysis induced by human tumors, neonatal mouse calvaria are cultured in sterile conditions in different media. Osteolysis is estimated by the amount of 45Ca released from bone to medium, the mice being given injections of 45Ca on their day of birth. An increased bone lysis is observed when calvaria are incubated in the same medium conditioned from cultured tumor fragments. This effect is significantly decreased when the mice have been treated with either ethanehydroxydiphosphonate or dichloromethylenediphosphonate. These experiments represent a first step in estimating the potential effects of different drugs on malignant osteolysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454481

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Authors:  H Fleisch
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 2.  Perspectives in the treatment of cancer metastasis.

Authors:  S Garattini
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

Review 3.  Clodronate: a review of its use in breast cancer.

Authors:  M Hurst; S Noble
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

4.  A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium.

Authors:  R Nemoto; K Uchida; M Tsutsumi; K Koiso; S Satou; T Satou
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 5.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

6.  Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK).

Authors:  M Tohkin; S Kakudo; H Kasai; H Arita
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

Review 7.  Development of bisphosphonates.

Authors:  Herbert Fleisch
Journal:  Breast Cancer Res       Date:  2001-11-30       Impact factor: 6.466

8.  Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.

Authors:  R Nemoto; Y Nishijima; K Uchida; K Koiso
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.